Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

New contract for UK GPs giving them more money and flexibility

A new GP contract will “fix the front door” of the NHS and bring back the family doctor, the government has announced. The new deal agreed with the British Medical Association (BMA) will free up doctors from box-ticking targets to concentrate on patients and take first steps to end the “8am scramble” for appointments. 

Clariane’s 2024 results boost share price

The share price of listed pan-European French elderly care group Clariane shot up 33% last week, after the release of 2024 results showing a return to profitability.

Activos presents elderly care roadmap at European Parliament

Spain-based pan-European REIT Healthcare Activos has presented a “strategic roadmap” for expanding Europe’s elderly care capacity to MEPs at the European Parliament, given that the continent’s 80+ population will roughly double by 2050. 

“AI should be seen as a tool, not a solution on its own” – in conversation with Martin Møller Paarse, COO, Liva Healthcare

In early February 2025, Liva Healthcare, a UK-based digital health company, acquired Discover Momenta and its subsidiary, Momenta Newcastle, for an undisclosed sum. Liva offers human-led therapeutic intervention programmes aimed at addressing chronic lifestyle diseases, such as type 2 diabetes. HBI caught up with Martin Møller Paarse, COO of Liva Healthcare, to explore the evolving digital healthcare landscape in the UK and Europe, along with investment opportunities, market consolidation, and Liva’s mission in the sector.

Fresenius surpasses expectations in 2024, driven by Kabi growth and strategic restructuring

Fresenius, Germany’s largest for-profit hospital group, has just released its 2024 annual results, and CEO Michael Sen’s “Future Fresenius” strategy is in full swing. The company beat market expectations for FY24 earnings, with strong performance from its hospital drug unit, Kabi. The unit saw a 21% jump in EBIT year-on-year, hitting €340 million, driven by solid revenue growth and better productivity.

Find Us